Proto-Oncogene Drgu Market Report

Global and Region Proto-Oncogene Drgu Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：219
  • REPORT CODE：GMM994758
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Proto-Oncogene Drgu market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Proto-Oncogene Drgumarket, defines the market attractiveness level of Proto-Oncogene Drgu market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Proto-Oncogene Drgu industry, describes the types of Proto-Oncogene Drgu market, the applications of major players and the market size, and deeply analyzes the current situation of the global Proto-Oncogene Drgu market and the development prospects and opportunities of Proto-Oncogene Drgu industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Proto-Oncogene Drgu market in Chapter 13.

    By Player:

    • Eisai Pharmaceuticals

    • AstraZeneca

    • GlaxoSmithKline

    • Exelixis

    • Bristol-Myers Squibb

    • Novartis

    • Pfizer

    • Bayer Healthcare

    • ARIAD Pharmaceuticals

    • Dexa Medica

    • ChemGenex Pharmaceuticals

    • Onyx Pharmaceuticals

    • Plexxikon

    By Type:

    • Axitinib (Inlyta)

    • Ponatinib (Iclusig)

    • Imatinib (Gleevec)

    • Sunitinib (Sutent)

    • Pazopanib (Votrient)

    • Dabrafenib (Tafinlar)

    • Vandetanib (Caprelsa)

    • Vemurafenib (Zelboraf)

    • Cabozantinib (Cabometyx and Cometriq)

    • Sorafenib (Nexavar)

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Proto-Oncogene Drgu Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Proto-Oncogene Drgu Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Proto-Oncogene Drgu Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Proto-Oncogene Drgu Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Proto-Oncogene Drgu Market Analysis and Outlook to 2022

    • 7.1 Global Proto-Oncogene Drgu Consumption (2017-2022)

    • 7.2 United States Proto-Oncogene Drgu Consumption (2017-2022)

    • 7.3 Europe Proto-Oncogene Drgu Consumption (2017-2022)

    • 7.4 China Proto-Oncogene Drgu Consumption (2017-2022)

    • 7.5 Japan Proto-Oncogene Drgu Consumption (2017-2022)

    • 7.6 India Proto-Oncogene Drgu Consumption (2017-2022)

    • 7.7 South Korea Proto-Oncogene Drgu Consumption (2017-2022)

    8 Region and Country-wise Proto-Oncogene Drgu Market Analysis and Outlook to 2028

    • 8.1 Global Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    • 8.2 United States Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    • 8.3 Europe Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    • 8.4 China Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    • 8.5 Japan Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    • 8.6 India Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    • 8.7 South Korea Proto-Oncogene Drgu Consumption Forecast (2022-2028)

    9 Global Proto-Oncogene Drgu Market Outlook by Types and Applications to 2022

    • 9.1 Global Proto-Oncogene Drgu Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Axitinib (Inlyta) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ponatinib (Iclusig) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Imatinib (Gleevec) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Sunitinib (Sutent) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Pazopanib (Votrient) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Dabrafenib (Tafinlar) Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Vandetanib (Caprelsa) Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Vemurafenib (Zelboraf) Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Cabozantinib (Cabometyx and Cometriq) Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Sorafenib (Nexavar) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Proto-Oncogene Drgu Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Proto-Oncogene Drgu Market Outlook by Types and Applications to 2028

    • 10.1 Global Proto-Oncogene Drgu Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Axitinib (Inlyta) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ponatinib (Iclusig) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Imatinib (Gleevec) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Sunitinib (Sutent) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Pazopanib (Votrient) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Dabrafenib (Tafinlar) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Vandetanib (Caprelsa) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Vemurafenib (Zelboraf) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Cabozantinib (Cabometyx and Cometriq) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Sorafenib (Nexavar) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Proto-Oncogene Drgu Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Proto-Oncogene Drgu Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Proto-Oncogene Drgu Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Proto-Oncogene Drgu Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Proto-Oncogene Drgu Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Proto-Oncogene Drgu Market Competitive Analysis

    • 14.1 Eisai Pharmaceuticals

      • 14.1.1 Eisai Pharmaceuticals Company Details

      • 14.1.2 Eisai Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eisai Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Proto-Oncogene Drgu Product and Service

    • 14.3 GlaxoSmithKline

      • 14.3.1 GlaxoSmithKline Company Details

      • 14.3.2 GlaxoSmithKline Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Proto-Oncogene Drgu Product and Service

    • 14.4 Exelixis

      • 14.4.1 Exelixis Company Details

      • 14.4.2 Exelixis Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Exelixis Proto-Oncogene Drgu Product and Service

    • 14.5 Bristol-Myers Squibb

      • 14.5.1 Bristol-Myers Squibb Company Details

      • 14.5.2 Bristol-Myers Squibb Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bristol-Myers Squibb Proto-Oncogene Drgu Product and Service

    • 14.6 Novartis

      • 14.6.1 Novartis Company Details

      • 14.6.2 Novartis Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novartis Proto-Oncogene Drgu Product and Service

    • 14.7 Pfizer

      • 14.7.1 Pfizer Company Details

      • 14.7.2 Pfizer Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pfizer Proto-Oncogene Drgu Product and Service

    • 14.8 Bayer Healthcare

      • 14.8.1 Bayer Healthcare Company Details

      • 14.8.2 Bayer Healthcare Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer Healthcare Proto-Oncogene Drgu Product and Service

    • 14.9 ARIAD Pharmaceuticals

      • 14.9.1 ARIAD Pharmaceuticals Company Details

      • 14.9.2 ARIAD Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 ARIAD Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • 14.10 Dexa Medica

      • 14.10.1 Dexa Medica Company Details

      • 14.10.2 Dexa Medica Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Dexa Medica Proto-Oncogene Drgu Product and Service

    • 14.11 ChemGenex Pharmaceuticals

      • 14.11.1 ChemGenex Pharmaceuticals Company Details

      • 14.11.2 ChemGenex Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 ChemGenex Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • 14.12 Onyx Pharmaceuticals

      • 14.12.1 Onyx Pharmaceuticals Company Details

      • 14.12.2 Onyx Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Onyx Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • 14.13 Plexxikon

      • 14.13.1 Plexxikon Company Details

      • 14.13.2 Plexxikon Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Plexxikon Proto-Oncogene Drgu Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Proto-Oncogene Drgu

    • Figure Proto-Oncogene Drgu Picture

    • Table Global Proto-Oncogene Drgu Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Proto-Oncogene Drgu Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Proto-Oncogene Drgu Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Proto-Oncogene Drgu Consumption by Country (2017-2022)

    • Figure United States Proto-Oncogene Drgu Consumption and Growth Rate (2017-2022)

    • Table Europe Proto-Oncogene Drgu Consumption and Growth Rate (2017-2022)

    • Figure China Proto-Oncogene Drgu Consumption and Growth Rate (2017-2022)

    • Figure Japan Proto-Oncogene Drgu Consumption and Growth Rate (2017-2022)

    • Figure India Proto-Oncogene Drgu Consumption and Growth Rate (2017-2022)

    • Figure South Korea Proto-Oncogene Drgu Consumption and Growth Rate (2017-2022)

    • Figure Global Proto-Oncogene Drgu Consumption Forecast by Country (2022-2028)

    • Figure United States Proto-Oncogene Drgu Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Proto-Oncogene Drgu Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Proto-Oncogene Drgu Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Proto-Oncogene Drgu Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Proto-Oncogene Drgu Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Proto-Oncogene Drgu Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Axitinib (Inlyta) Consumption and Growth Rate (2017-2022)

    • Figure Global Ponatinib (Iclusig) Consumption and Growth Rate (2017-2022)

    • Figure Global Imatinib (Gleevec) Consumption and Growth Rate (2017-2022)

    • Figure Global Sunitinib (Sutent) Consumption and Growth Rate (2017-2022)

    • Figure Global Pazopanib (Votrient) Consumption and Growth Rate (2017-2022)

    • Figure Global Dabrafenib (Tafinlar) Consumption and Growth Rate (2017-2022)

    • Figure Global Vandetanib (Caprelsa) Consumption and Growth Rate (2017-2022)

    • Figure Global Vemurafenib (Zelboraf) Consumption and Growth Rate (2017-2022)

    • Figure Global Cabozantinib (Cabometyx and Cometriq) Consumption and Growth Rate (2017-2022)

    • Figure Global Sorafenib (Nexavar) Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Axitinib (Inlyta) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ponatinib (Iclusig) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Imatinib (Gleevec) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sunitinib (Sutent) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pazopanib (Votrient) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dabrafenib (Tafinlar) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vandetanib (Caprelsa) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vemurafenib (Zelboraf) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cabozantinib (Cabometyx and Cometriq) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sorafenib (Nexavar) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Proto-Oncogene Drgu Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Proto-Oncogene Drgu Export by Region (Top 5 Countries) (2017-2028)

    • Table Eisai Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Eisai Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Proto-Oncogene Drgu Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Proto-Oncogene Drgu Product and Service

    • Table Exelixis (Foundation Year, Company Profile and etc.)

    • Table Exelixis Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exelixis Proto-Oncogene Drgu Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Proto-Oncogene Drgu Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Proto-Oncogene Drgu Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Proto-Oncogene Drgu Product and Service

    • Table Bayer Healthcare (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Proto-Oncogene Drgu Product and Service

    • Table ARIAD Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ARIAD Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARIAD Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • Table Dexa Medica (Foundation Year, Company Profile and etc.)

    • Table Dexa Medica Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dexa Medica Proto-Oncogene Drgu Product and Service

    • Table ChemGenex Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ChemGenex Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table ChemGenex Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • Table Onyx Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Onyx Pharmaceuticals Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Onyx Pharmaceuticals Proto-Oncogene Drgu Product and Service

    • Table Plexxikon (Foundation Year, Company Profile and etc.)

    • Table Plexxikon Proto-Oncogene Drgu Sales, Price, Value and Gross Profit (2017-2022)

    • Table Plexxikon Proto-Oncogene Drgu Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US